Armata Pharmaceuticals, Inc.(Borse Stuttgart : ARMP)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.90% | 168.39 | 1.3% | $496.78m | |
| BIIB | Biogen Inc. | 0.65% | 230.76 | 1.3% | $480.84m | |
| CELG | Celgene Corporation | -0.62% | 94.83 | 1.3% | $471.13m | |
| GILD | Gilead Sciences, Inc. | -0.75% | 65.86 | 0.9% | $453.88m | |
| ILMN | Illumina, Inc. | -2.29% | 300.59 | 3.5% | $305.96m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.78% | 302.57 | 2.6% | $276.84m | |
| A | Agilent Technologies, Inc. | -0.29% | 68.91 | 1.6% | $198.64m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.78% | 165.73 | 1.9% | $176.80m | |
| EXAS | Exact Sciences Corporation | -0.16% | 96.04 | 25.3% | $171.72m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -2.80% | 127.23 | 2.0% | $150.06m | |
| BMRN | BioMarin Pharmaceutical Inc. | -2.31% | 86.66 | 4.3% | $118.53m | |
| SRPT | Sarepta Therapeutics, Inc. | -3.37% | 117.57 | 14.7% | $114.20m | |
| INCY | Incyte Corporation | -0.48% | 76.83 | 2.5% | $105.26m | |
| IONS | Ionis Pharmaceuticals, Inc. | 0.09% | 67.46 | 8.2% | $98.12m | |
| ALNY | Alnylam Pharmaceuticals, Inc | -2.49% | 65.86 | 9.2% | $93.34m |
Company Profile
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. Its product candidate is the AP-SA01 that targets Staphylococcus aureus, including multidrug-resistant strains. The company was founded on May 9, 2019 and is headquartered in Los Angeles, CA.